StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$12.75−0.40 (-3.04%)

Close on Nov 16, 2026Market cap $86.56MP/E –Yield –

Eloxx Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Eloxx Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2012 was -2705.8%. For fiscal 2024 it was -38.8%, against -5019.9% the year before. The highest annual figure on record is -38.8% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-38.8%+4981.1
FY2014Jun 30, 2014-5019.9%+54457.0
FY2013Jun 30, 2013-59476.9%−56771.2
FY2012Jun 30, 2012-2705.8%+756.0
FY2010Jun 30, 2010-3461.8%–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?